Retention of basic fibroblast growth factor immunoreactivity in dopaminergic neurons of the substantia nigra during normal aging in humans contrast with loss in Parkinson's disease
- 5 September 1994
- journal article
- research article
- Published by Elsevier in Brain Research
- Vol. 656 (1) , 165-168
- https://doi.org/10.1016/0006-8993(94)91378-1
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Protection from 1-methyl-4-phenylpyridinium (MPP+) toxicity and stimulation of regrowth of MPP+-damaged dopaminergic fibers by treatment of mesencephalic cultures with EGF and basic FGFBrain Research, 1992
- AGEING AND PARKINSON'S DISEASE: SUBSTANTIA NIGRA REGIONAL SELECTIVITYBrain, 1991
- Basic FGF is present in dopaminergic neurons of the ventral midbrain of the ratNeuroReport, 1991
- The neurotrophic effects of fibroblast growth factors on dopaminergic neurons in vitro are mediated by mesencephalic glia [published erratum appears in J Neurosci 1992 Mar;12(3):685]Journal of Neuroscience, 1991
- Basic FGF reverses chemical and morphological deficits in the nigrostriatal system of MPTP-treated miceJournal of Neuroscience, 1990
- Selective and nonselective stimulation of central cholinergic and dopaminergic development in vitro by nerve growth factor, basic fibroblast growth factor, epidermal growth factor, insulin and the insulin-like growth factors I and IIJournal of Neuroscience, 1990
- Basic fibroblast growth factor promotes the survival and development of mesencephalic neurons in cultureDevelopmental Biology, 1989
- Rate of cell death in parkinsonism indicates active neuropathological processAnnals of Neurology, 1988
- ALZHEIMER'S DISEASE, PARKINSON'S DISEASE, AND MOTONEURONE DISEASE: ABIOTROPIC INTERACTION BETWEEN AGEING AND ENVIRONMENT?The Lancet, 1986
- Aging and Extrapyramidal FunctionArchives of Neurology, 1977